Expression of cyclooxygenase-2, vascular endothelial growth factor and matrix metalloproteinase-2 in patients with primary laryngeal carcinoma: A tissue microarray study

Journal of Laryngology and Otology

Volumn 121, Issue 12, 2007, Pages 1177-1183

  Dong, P ^a   Li, X ^a   Yu, Z ^a   Lu, G ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Angiogenesis; COX 2; Head and Neck Neoplasms; Immunohistochemistry; Larynx Neoplasms; Microarray Analysis; MMP 2; Prognosis

Indexed keywords

CYCLOOXYGENASE 2; GELATINASE A; VASCULOTROPIN; TUMOR MARKER; TUMOR PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER GROWTH; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CORRELATION COEFFICIENT; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; LARYNX CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; OVERALL SURVIVAL; PATHOLOGY; PROGNOSIS; PROTEIN EXPRESSION; SEX DIFFERENCE; SQUAMOUS CELL CARCINOMA; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; SURVIVAL TIME; TISSUE MICROARRAY; ENZYME IMMUNOASSAY; LARYNX TUMOR; METABOLISM; METASTASIS; METHODOLOGY; MIDDLE AGED; SURVIVAL;

AGED; CARCINOMA, SQUAMOUS CELL; CYCLOOXYGENASE 2; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; LARYNGEAL NEOPLASMS; LYMPHATIC METASTASIS; MALE; MATRIX METALLOPROTEINASE 2; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASM STAGING; PROGNOSIS; SURVIVAL ANALYSIS; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 40449126862     PISSN: 00222151     EISSN: 17485460     Source Type: Journal    
DOI: 10.1017/S002221510700031X     Document Type: Article

References (34)

1. Lin CC, Kenyon L, Hyslop T, Hammond E, Andrews DW, Curran WJ Jr et al. Cyclooxygenase-2 (COX-2) expression in human meningioma as a function of tumor grade. Am J Clin Oncol 2003;26:98-102
2. Bodey B, Siegel SE, Kaiser HE. Cyclooxygenase-2 (COX-2) overexpression in childhood brain tumors. In Vivo 2006;20:519-25
3. Chan G, Boyle JO, Yang EK, Zhang F, Sacks PG, Shah JP et al. Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of head and neck. Cancer Res 1999;59:991-4
4. Li W, Xu RJ, Zhang HH, Jiang LH. Overexpression of cyclooxygenase-2 correlates with tumor angiogenesis in endometrial carcinoma. J Gynecol Cancer 2006;16:1673-8
5. Miura S, Tatsuguchi A, Wada K, Takeyama H, Shinji Y, Hiratsuka T et al. Cyclooxygenase-2-regulated vascular endothelial growth factor release in gastric fibroblasts. Am J Physiol Gastrointest Liver Physiol 2004;287:G444-51
6. Abe M, Sato Y. cDNA microarray analysis of the gene expression profile of VEGF-activated human umbilical vein endothelial cells. Angiogenesis 2001;4:289-98
7. Miyata Y, Koga S, Kanda S, Nishikido M, Hayashi T, Kanetake H. Expression of cyclooxygenase-2 in renal cell carcinoma: correlation with tumor cell proliferation, apoptosis, angiogenesis, expression of matrix metalloproteinase-2, and survival. Clin Cancer Res 2003;9:1741-9
8. Attiga FA, Fernandez PM, Weeraratna AT, Manyak MJ, Patierno SR. Inhibitors of prostaglandin synthesis inhibit human prostate tumor cell invasiveness and reduce the release of matrix metalloproteinases. Cancer Res 2000;60:4629-37
9. Sivula A, Talvensaari-Mattila A, Lundin J, Joensuu H, Haglund C, Ristimaki A et al. Association of cyclooxygenase-2 and matrix metalloproteinase-2 expression in human breast cancer. Breast Cancer Res Treat 2005;89:215-20
10. Kuwamori T, Rao CV, Seibert K, Reddy BS. Chemopreventive activity of celeCOXib, a specific cyclooxygenese-2 inhibitor, against colon carcinogenesis. Cancer Res 1998;58:409-12
11. Wan WH, Fortuna MB, Furmanski P. A rapid and efficient method for testing immunohistochemical reactivity of monoclonal antibodies against multiple tissue samples simultaneously. J Immunol Methods 1987;103:121-9
12. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin 2007;57:43-66
13. Kononen J, Bubendorf L, Kallioniemi A, Barlund M, Schraml P, Leighton S et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 1998;4:844-7
14. Mobasheri A, Airley R, Hewitt SM, Marples D. Heterogeneous expression of the aquaporin 1 (AQP1) water channel in tumors of the prostate, breast, ovary, colon and lung: a study using high density multiple human tumor tissue microarrays. J Oncol 2005;26:1149-58
15. Bhargava R, Lal P, Chen B. Feasibility of using tissue microarrays for the assessment of HER-2 gene amplification by fluorescence in situ hybridization in breast carcinoma. Diagn Mol Pathol 2004;13:213-16
16. Koynova DK, Tsenova VS, Jankova RS, Gurov PB, Toncheva DI. Tissue microarray analysis of EGFR and HER2 oncogene copy number alterations in squamous cell carcinoma of the larynx. J Cancer Res Clin Oncol 2005;131:199-203
17. Freier K, Bosch FX, Flechtenmacher C, Devens F, Benner A, Lichter P et al. Distinct site-specific oncoprotein overexpression in head and neck squamous cell carcinoma: a tissue microarray analysis. Anticancer Res 2003;23:3971-7
18. Peters S, Hambek M, Gstottner W, Knecht R. Tissue microarrays. Value of immunohistochemical proliferation markers for serial investigations of head and neck cancer [in German]. HNO 2004;52:409-12
19. Young-Ae C, Dong-jun L, Hyung-Kyu L, Jae-Ho J, Jong-Kyung S, Shin-Sung K et al. Interleukin-1β stimulates matrix metalloproteinase-2 expression via prostaglandin E2-dependent mechanism in human chondrocytes. Experimental and Molecular Medicine 2004;36:226-32
20. Del Bufalo D, Trisciuoglio D, Scarsella M, D'Amati G, Candiloro A, Iervolino A et al. Lonidamine causes inhibition of angiogenesis-related endothelial cell functions. Neoplasia 2004;6:513-22
21. Lara-Pezzi E, Gomez-Gaviro MV, Galvez BG, Mira E, Iniguez MA, Fresno M et al. The hepatitis B virus X protein promotes tumor cell invasion by inducing membrane-type matrix metalloproteinase-1 and cyclooxygenase 2 expression. J Clin Invest 2002;110:1821-8
22. Williams CS, Mann M, Dubois RN. The role of cyclooxygenases in inflammation, cancer and development. Oncogene 1996;18:7908-16
23. Theret N, Musso O, Turlin B, Lotrian D, Bioulac-Sage P, Campion JP et al. Increased extracellular matrix remodeling is associated with tumor progression in human hepatocellular carcinomas. Hepatology 2001;34:82-8
24. Sano H, Kawahito Y, Wilder RL, Hashiramoto A, Mukai S, Asai K et al. Expression of cyclooxygenase-1 and 2 in human colorectal cancer. Cancer Res 1995;55:3785-9
25. Gallo O, Franchi A, Magnelli L, Sardi I, Vannacci A, Boddi V et al. Cyclooxygenase-2 pathway correlates with VEGF expression in head and neck cancer: implications for tumor angiogenesis and metastases. Neoplasia 2001;3:53-61
26. Shintani S, Li C, Ishikawa T, Mihara M, Nakashiro K, Hamakawa H. Expression of vascular endothelial growth factor A, B, C and D in oral squamous cell carcinoma. Oral Oncol 2004;40:13-20
27. Callejas NA, Casado M, Diaz-Guerra MJ, Bosca L, Martin-Sanz P. Expression of cyclooxygenase-2 promotes the release of matrix metalloproteinase-2 and -9 in fetal rat hepatocytes. Hepatology 2001;33:860-7
28. Shankavaram UT, Lai WC, Netzel-Arnett S, Mangan PR, Ardans JA, Caterina N et al. Monocyte membrane type 1-matrix metalloproteinase. Prostaglandin-dependent regulation and role in metalloproteinase-2 activation. J Bio Chem 2001;276:19027-32
29. Choi EY, Kim D, Hong BK, Kwon HM, Song YG, Byun KH et al. Upregulation of extracellular matrix metalloproteinase inducer (EMMPRIN) and gelatinases in human atherosclerosis infected with Chlamydia pneumoniae. The potential role of Chlamydia pneumoniae infection in the progression of atherosclerosis. Exp Mol Med 2002;34:391-400
30. Smalley W, Du Bois RN. Colorectal cancer and nonsteroidal anti-inflammatory drugs. Adv Pharmacol 1997;39:1-20
31. Sheng H, Shao J, Kirkland SC, Isakson P, Coffey RJ, Morrow J et al. Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2. J Clin Invest 1997;99:2254-9
32. Ondrey FG, Juhn SK, Adams GL. Inhibition of head and neck tumor cell growth with arachidonic acid metabolism inhibition. Laryngoscope 1996;106:129-34
33. Scioscia KA, Snyderman CH, Rueger R, Reddy J, D'Amico F, Comsa S et al. Role of arachidonic acid metabolites in tumor growth inhibition by nonsteroidal anti-inflammatory drugs. Am J Otolaryngol 1997;18:1-8
34. Panje WR. Regression of head and neck carcinoma with a prostaglandin-synthesis inhibitor. Arch Otolaryngol 1998;107:658- 63